Robert Schwartz is a patent attorney who focuses on biotechnology and pharmaceutical patent litigation, contested cases before the United States Patent and Trademark Office (USPTO), technical counseling, and patentability and non-infringement opinions. Bob’s primary areas of experience are in biotechnology – particularly protein biochemistry, cell biology, immunology, molecular biology, genomics, proteomics – and the chemical arts. He has worked with transgenic mice, antibodies, fusion proteins, enzyme inhibitors, cell growth factors, receptor antagonists, nucleotide sequencing technology, antiviral drugs, prodrugs, and vaccines.
Prior to becoming an attorney, Bob was a professor in the department of medicine at the Albert Einstein College of Medicine, where he was a principal investigator conducting grant-funded biomedical research in hereditary anemias, malaria, and diabetes. He also worked as a staff scientist at Children's Hospital Oakland Research Institute (CHORI).